Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma

As one of the most common malignant tumors worldwide, hepatocellular carcinoma (HCC) is known for its poor prognosis due to diagnosis only in advanced stages. Nearly 50% of the patients with the first diagnosis of HCC die within a year. Currently, the advancements in the integration of omics informa...

Full description

Saved in:
Bibliographic Details
Published in:Int J Biol Sci
Main Authors: Wu, Xiaolin, Li, Jiahui, Gassa, Asmae, Buchner, Denise, Alakus, Hakan, Dong, Qiongzhu, Ren, Ning, Liu, Ming, Odenthal, Margarete, Stippel, Dirk, Bruns, Christiane, Zhao, Yue, Wahba, Roger
Format: Artigo
Language:Inglês
Published: Ivyspring International Publisher 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097921/
https://ncbi.nlm.nih.gov/pubmed/32226301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44024
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items